ZA83628B - Pharmacologically active pyrazolo/4,3-/pyridines - Google Patents

Pharmacologically active pyrazolo/4,3-/pyridines

Info

Publication number
ZA83628B
ZA83628B ZA83628A ZA83628A ZA83628B ZA 83628 B ZA83628 B ZA 83628B ZA 83628 A ZA83628 A ZA 83628A ZA 83628 A ZA83628 A ZA 83628A ZA 83628 B ZA83628 B ZA 83628B
Authority
ZA
South Africa
Prior art keywords
pyridines
pharmacologically active
pyrazolo
active pyrazolo
neuroleptic
Prior art date
Application number
ZA83628A
Other languages
English (en)
Inventor
Giorgio Winters
Alberto Sala
Domenico Barone
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Publication of ZA83628B publication Critical patent/ZA83628B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA83628A 1982-02-17 1983-01-31 Pharmacologically active pyrazolo/4,3-/pyridines ZA83628B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8204722 1982-02-17

Publications (1)

Publication Number Publication Date
ZA83628B true ZA83628B (en) 1983-12-28

Family

ID=10528419

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA83628A ZA83628B (en) 1982-02-17 1983-01-31 Pharmacologically active pyrazolo/4,3-/pyridines

Country Status (16)

Country Link
US (1) US4500525A (zh)
EP (1) EP0086422B1 (zh)
JP (1) JPS58152885A (zh)
KR (1) KR900006853B1 (zh)
AT (1) ATE30027T1 (zh)
AU (1) AU563591B2 (zh)
CA (1) CA1225646A (zh)
DE (1) DE3373904D1 (zh)
DK (1) DK27383A (zh)
ES (3) ES8500273A1 (zh)
GR (1) GR78080B (zh)
IE (1) IE55156B1 (zh)
IL (1) IL67785A0 (zh)
NZ (1) NZ203302A (zh)
PH (1) PH23645A (zh)
ZA (1) ZA83628B (zh)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5137890A (en) * 1990-02-14 1992-08-11 Ortho Pharmaceutical Corporation 4-phenyl tetrahydropyrido(4,3-d)pyrimidines
US5264576A (en) * 1992-10-22 1993-11-23 Hoechst-Roussel Pharmaceuticals Incorporated Pyrazolo[4,3-c]pyridines which are intermediates
DE19834044A1 (de) * 1998-07-29 2000-02-03 Bayer Ag Neue substituierte Pyrazolderivate
US20070117785A1 (en) * 2000-08-14 2007-05-24 Butler Christopher R Substituted pyrazoles and methods of treatment with substituted pyrazoles
US7332494B2 (en) 2000-08-14 2008-02-19 Janssen Pharmaceutica, N.V. Method for treating allergies using substituted pyrazoles
US20070105841A1 (en) * 2000-08-14 2007-05-10 Breitenbucher J G Method for treating allergies using substituted pyrazoles
MXPA03001422A (es) 2000-08-14 2004-01-26 Johnson & Johnson Pirazoles substituidos.
MXPA03001420A (es) * 2000-08-14 2004-01-26 Johnson & Johnson Pirazoles sustituidos.
US20050101587A9 (en) * 2000-08-14 2005-05-12 Butler Christopher R. Method for treating allergies using substituted pyrazoles
AU8125501A (en) * 2000-08-14 2002-02-25 Ortho Mcneil Pharm Inc Substituted pyrazoles
MXPA03001964A (es) * 2000-09-06 2004-03-26 Johnson & Johnson Metodo para el tratamiento de alergias usando pirazoles substituidos.
AU2001288714A1 (en) 2000-09-06 2002-03-22 Ortho-Mcneil Pharmaceutical, Inc. A method for treating allergies
AU2003231880A1 (en) * 2002-05-30 2003-12-19 Vertex Pharmaceuticals Incorporated Inhibitors of jak and cdk2 protein kinases
AU2003244632A1 (en) * 2002-07-25 2004-02-25 Pharmacia Italia S.P.A. Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
EP2243781A1 (en) * 2003-05-30 2010-10-27 Vertex Pharmaceuticals, Inc. Pyrazolopyridine derivatives as inhibitors of JAK and CDK2 protein kinases
CN103788089A (zh) 2003-09-17 2014-05-14 詹森药业有限公司 作为血清素受体调节剂的稠合杂环化合物
US7652135B2 (en) 2003-09-23 2010-01-26 Vertex Pharmaceuticals Incorporated Compositions useful as inhibitors of protein kinases
KR100838692B1 (ko) 2007-07-11 2008-06-16 한국화학연구원 7-(3′,4′-디알콕시페닐)-4,5,6,7-테트라히드로피라졸로[1,5-ａ]피리미딘 화합물, 이의 제조방법 및 이를 포함하는천식 및 만성폐쇄성 폐질환을 포함한 염증관련 질환,관절염, 아토피 피부염, 암 및 뇌질환의 치료 및 예방을위한 약제학적 조성물
EP2615916B1 (en) * 2010-09-16 2017-01-04 Merck Sharp & Dohme Corp. Fused pyrazole derivatives as novel erk inhibitors
EA023648B1 (ru) * 2011-09-12 2016-06-30 Санофи ИНДАНИЛЗАМЕЩЕННЫЕ 4,5,6,7-ТЕТРАГИДРО-1H-ПИРАЗОЛО[4,3-с]ПИРИДИНЫ, ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ЛЕКАРСТВЕННОГО СРЕДСТВА И СОДЕРЖАЩИЕ ИХ ФАРМАЦЕВТИЧЕСКИЕ ПРЕПАРАТЫ
SI2755972T1 (sl) 2011-09-12 2016-02-29 Sanofi Indanil-substituirani 4,5,6,7-tetrahidro-1H-pirazolo(4,3-c)piridini, njihova uporaba kot zdravilo in farmacevtski pripravki, ki jih vsebujejo
WO2013037415A1 (en) * 2011-09-16 2013-03-21 Sanofi Substituted 4,5,6,7-tetrahydro-1h-pyrazolo[4,3-c]pyridines, their use as medicament, and pharmaceutical preparations comprising them
WO2013037914A1 (en) 2011-09-16 2013-03-21 Sanofi Substituted 4,5,6,7-tetrahydro-1h-pyrazolo[4,3-c]pyridines, their use as medicament, and pharmaceutical preparations comprising them
US9518057B2 (en) * 2014-12-30 2016-12-13 Novira Therapeutics, Inc. Derivatives and methods of treating hepatitis B infections
JP7014736B2 (ja) * 2016-05-24 2022-02-01 ジェネンテック， インコーポレイテッド がんの処置のためのピラゾロピリジン誘導体
WO2018005881A1 (en) 2016-06-29 2018-01-04 Novira Therapeutics, Inc. Oxadiazepinone derivatives and their use in the treatment of hepatitis b infections
JP6935433B2 (ja) 2016-06-29 2021-09-15 ノヴィラ・セラピューティクス・インコーポレイテッド ジアゼピノン誘導体及びｂ型肝炎感染症の治療におけるその使用
CN110997674B (zh) 2017-05-31 2022-12-20 凯莫森特里克斯股份有限公司 作为C5a抑制剂的6-5稠合环类
CN111788185A (zh) * 2017-12-22 2020-10-16 凯莫森特里克斯股份有限公司 作为C5a抑制剂的二芳基取代的6,5稠合环化合物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3852279A (en) * 1973-03-12 1974-12-03 Squibb & Sons Inc 7-substituted -3,3a,4,5,6,7-hexahydro-3-substituted-2h- pyrazolo (4,3-c)pyridines

Also Published As

Publication number Publication date
JPS58152885A (ja) 1983-09-10
ES519832A0 (es) 1984-10-01
ES531980A0 (es) 1985-09-01
EP0086422A3 (en) 1984-03-28
CA1225646A (en) 1987-08-18
IL67785A0 (en) 1983-05-15
ES531981A0 (es) 1985-09-01
KR900006853B1 (ko) 1990-09-22
DK27383D0 (da) 1983-01-25
DE3373904D1 (en) 1987-11-05
US4500525A (en) 1985-02-19
IE830328L (en) 1983-08-17
EP0086422B1 (en) 1987-09-30
AU563591B2 (en) 1987-07-16
AU1130583A (en) 1983-08-25
NZ203302A (en) 1986-08-08
GR78080B (zh) 1984-09-26
IE55156B1 (en) 1990-06-20
PH23645A (en) 1989-09-27
JPH0412269B2 (zh) 1992-03-04
ES8507547A1 (es) 1985-09-01
DK27383A (da) 1983-08-18
KR840003636A (ko) 1984-09-15
ES8500273A1 (es) 1984-10-01
EP0086422A2 (en) 1983-08-24
ES8507546A1 (es) 1985-09-01
ATE30027T1 (de) 1987-10-15

Similar Documents

Publication Publication Date Title
ZA83628B (en) Pharmacologically active pyrazolo/4,3-/pyridines
ES8801785A1 (es) Un procedimiento para la preparacion de nuevas azetidinonas sustituidas.
IL72120A0 (en) 2-pyrimidinyl-1-piperazine derivatives,their preparation and pharmaceutical compositions containing them
HUT70505A (en) Pyrrolo[2,3-d]pyrimidine derivatives, pharmaceutical compositions containing them and process for preparing them
JO1502B1 (en) New pharmacy vehicles
YU211087A (en) Process for obtaining new n-substituted benzimidazolic derivatives
DE3571982D1 (en) Benzisoselenazolethiones,process for their preparation and pharmaceutical products containing these compounds
ES8503685A1 (es) Un procedimiento para preparar derivados de pirazolo (3,4-b) piridina
MX9403088A (es) Composiciones farmaceuticas que contienen deriva- dos de indol y metodos de uso.
JO1406B1 (en) Chemical compounds
ES8400076A1 (es) Procedimiento para hidroformilar compuestos olefinicamente insaturados.
ZA848140B (en) New benzenesulfonyl-lactams,process for their preparation and their use as active substances of pharmaceutical compositions
ES8305684A1 (es) Procedimiento para la obtencion de derivados aminopropanolicos de 2-hidroxi b-fenil-propiofenonas.
AU573899B2 (en) Pyrazolo(3,4-b)-pyridine amided
PH23486A (en) Indole analogs of mevalonolactone,pharmaceutical compositions containing the same and method of use thereof
ATE69227T1 (de) Pharmakologisch wirksame pyrazolopyridine.
ES8608516A1 (es) Procedimiento para la preparacion de acidos 4-isoxazolil- tiazol-2-oxamicos y sus derivados
ES8504774A1 (es) Procedimiento para preparar derivados de 2-piperacinil-quinazolina
IL65490A0 (en) 5-substituted 4-oxo-pg1 derivatives,bicyclic compounds of the similar structure,and process for the preparation thereof and pharmaceutical compositions containing them
TW367320B (en) Novel aryl compounds having CNS activity, process for their preparation and their use as medicaments
IL68194A0 (en) Pharmaceutical preparation containing indolizino indole derivatives,novel compounds of this type and process for their preparation